Sector Gamma As Regeneron Pharmaceuticals, Inc. Transaction History

Sector Gamma As

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$574.03 - $680.96 $2.8 Million - $3.32 Million	-4,876 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $2.18 Million - $2.67 Million	4,876 New	4,876 $2.31 Million
Q1 2020 May 11, 2020	SELL	$336.18 - $494.43 $9.57 Million - $14.1 Million	-28,458 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$274.13 - $376.51 $13 Million - $17.8 Million	-47,377 Reduced 62.47%	28,458 $10.7 Million
Q3 2019 Nov 05, 2019	BUY	$273.46 - $318.39 $4.98 Million - $5.79 Million	18,200 Added 31.58%	75,835 $21 Million
Q2 2019 Jul 31, 2019	BUY	$299.6 - $414.82 $17.3 Million - $23.9 Million	57,635 New	57,635 $18 Million
Q3 2018 Nov 08, 2018	SELL	$351.14 - $408.51 $10 Million - $11.6 Million	-28,500 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$284.6 - $344.99 $8.11 Million - $9.83 Million	28,500 New	28,500 $9.83 Million

1,463

84.5M

907K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.